Answering a research question robustly requires pre-specification of the study design and all its component parts in a protocol.
Research designs can include, but are not limited to, randomised controlled trials, observational comparisons and qualitative studies.
A key requirement of any research study is to ensure that the study has sufficient scientific merit to answer, in a robust way, the main question (outlined in part 1 of 2; Lane, BJOG 2018; 125:1057) . Paramount to this is the research design, which encompasses the methods and procedures required to conduct the study. This should provide a logical structure of enquiry for the research question and hypothesis testing. The purpose of the research design is to reduce ambiguities, including bias, and provide strong evidence to support or reject a particular hypothesis.
The research question might take many different forms. For example, it may be driven by the need to evaluate an intervention, drug or procedure, e.g. medication to reduce blood loss following delivery (Bellad et al., BJOG 2012; 119: 975-86) ; or by the wish to delineate the relationship between exposure and outcome, e.g. eating disorder and small-forgestational-age (Micali et al., BJOG 2016; 123:1301-10) ; or even by the desire to explore the experiences of women having a particular type of care, e.g. home pregnancy termination (Purcell et al., BJOG 2017; 124:2001-8) . The insights of patients, their family members and carers, and the public are increasingly recognised as being key to understanding the feasibility of various design options when planning a study. If applied research is about generating evidence for the provision of better care, then it should seek the input of people who will use it in real life.
Often, a key step in the process is to determine the comparator group. For most research studies evaluating a new intervention, the comparator group should be what is considered treatment as usual, e.g. when assessing sublingual misoprostol for reducing postpartum blood loss the comparator may be the standard of care based on oxytocin (Bellad et al., BJOG 2012; 119:975-82) . For research studies determining the relationship between exposure and outcomes, the comparator group will be subjects not exposed; an example might be a comparison of pregnant women who have anorexia and bulimia nervosa versus those that do not (Micali et al., BJOG 2016; 123:1301-10) . Not all studies will have a comparator group (i.e. qualitative studies).
Once the research question (participants, interventions or exposures, and outcomes) and the type of study design have been determined, it is necessary to decide the time-scale of the study, the number of participants, what data to collect and which statistical or qualitative methods will be used to analyse it. These should all be included a priori in the study protocol, the reference document for the conduct of the study.
It is important not to become roped into the randomised trials strait jacket (Hariton et al., BJOG 2018; https://doi. org/10.1111 /1471 Hemming et al., BJOG 2018; https://doi.org/10.1111 / 1471 ). The preferred design will be methodologically sound for addressing the question and, as well as being practically feasible, it will be ethically justifiable.
Useful resources
The equator network website provides checklists for writing protocols of various study designs: http://www.equator-ne twork.org
The following BJOG article outlines how best to involve patients and public from the outset to improve the quality of women's health research (Moss et al., BJOG 2017; 124:362-5) . 
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